Pheochromocytoma
Showing 26 - 50 of 166
Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome Trial in San Antonio (Genetic screening)
Recruiting
- Pheochromocytoma
- +7 more
- Genetic screening
-
San Antonio, TexasUniversity of Texas Health Science Center
Aug 25, 2022
Metabolic Myopathy in Endocrinopathy
Not yet recruiting
- Cushing Syndrome
- +3 more
- Muscle biopsy
- (no location specified)
Jul 12, 2022
Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Minneapolis (131 I-Metaiodobenzylguanidine (131I-MIBG), Potassium
Recruiting
- Relapsed Neuroblastoma
- Metastatic Pheochromocytoma
- 131 I-Metaiodobenzylguanidine (131I-MIBG)
- +3 more
-
Minneapolis, MinnesotaUniversity of Minnesota Masonic Cancer Center
Jan 20, 2022
Development ofTele-monitoring Program for Patients Undergoing
Recruiting
- Pheochromocytoma
- Paraganglioma
- Use of an internet plateform
-
Paris, FranceHopital européen Georges Pompidou
Jan 17, 2022
Genetic Factors and Pheochromocytomas in Neoplasia Type 2
Recruiting
- Neoplasia
- Pheochromocytoma
-
Marseille, FranceAPHM - Hôpital de la Conception
Jan 30, 2022
Adrenal Diseases- Laparoscopic vs. Robotic-assisted
Recruiting
- Adrenal Tumor
- +12 more
-
Olomouc, CzechiaUniversity hospital Olomouc
Sep 17, 2023
Magnesium and Dexmedetomidine in Pheochromocytoma
Completed
- Phaeochromocytoma Crisis
- Hemodynamic Instability
- (no location specified)
Oct 20, 2021
Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Dallas (131 I-Metaiodobenzylguanidine, Potassium Iodide, G-csf)
No longer available
- Relapsed Neuroblastoma
- Metastatic Pheochromocytoma
- 131 I-Metaiodobenzylguanidine
- +2 more
-
Dallas, TexasThe University of Texas Southwestern Medical Center
Apr 13, 2022
Advanced or Metastatic Paraganglioma/ Pheochromocytoma Trial in Nanjing (Anlotinib)
Recruiting
- Advanced or Metastatic Paraganglioma/ Pheochromocytoma
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical Univerity
Nov 17, 2021
Paraganglioma, Pheochromocytoma Trial in Canada, Netherlands (Sunitinib)
Active, not recruiting
- Paraganglioma
- Pheochromocytoma
-
Calgary, Alberta, Canada
- +3 more
Nov 29, 2021
DOTATOC PET/CT for Imaging NET Patients
Recruiting
- Neuroendocrine Tumors
- +15 more
- 68Ga-DOTATOC PET/CT
- 18F-FDG PET/CT
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 2, 2022
Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131
Available
- Neuroblastoma
- Childhood Metastatic Pheochromocytoma
- 131 I-Metaiodobenzylguanidine (131 I-MIBG)
- 131 I-MIBG
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Jul 11, 2022
Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma Trial in Worldwide (EO2401)
Recruiting
- Adrenocortical Carcinoma
- +2 more
- EO2401
-
Houston, Texas
- +9 more
Dec 7, 2021
Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester
Not yet recruiting
- Neuroendocrine Tumors
- +8 more
-
Iowa City, Iowa
- +1 more
Nov 23, 2022
Pheochromocytoma Trial in Cairo (Dexmedetomidine, General anesthetic)
Completed
- Pheochromocytoma
- Dexmedetomidine
- General anesthetic
-
Cairo, EgyptDepartment of Anesthesia and Pain medicine.National Cancer Insti
Aug 30, 2021
China Adrenal Disease Registry
Recruiting
- Cushing Syndrome
- +7 more
-
Shanghai, ChinaEndocrinology
Jan 28, 2022
Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE
Not yet recruiting
- Bronchial and Thymic Neuroendocrine Tumour
- +3 more
- Lu-177 DOTATATE (Lutathera®)
- (no location specified)
Nov 1, 2023
Adrenal and Other Endocrine Tumors in Patients With Sudden Death
Recruiting
- Primary Aldosteronism
- +3 more
- Adrenal aldosterone synthase (CYP11B2) staining
- +2 more
-
Helsinki, FinlandEndocrinology, Helsinki University Hospital and University of He
Jul 8, 2022
Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer
Recruiting
- Adrenal Gland Pheochromocytoma
- +3 more
- Computed Tomography
- +2 more
-
Bethesda, Maryland
- +1 more
Jan 3, 2023
Selective Versus Nonselective Alpha-blockade Prior to
Completed
- Pheochromocytoma
- Selective alpha-1-antagonist
- Non-selective alpha-1-antagonist
-
Kraków, Polska, Poland2nd Department of General Surgery, Jagiellonian University Medic
Jun 15, 2021
Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)
Recruiting
- Pulmonary Neuroendocrine Neoplasm
- +9 more
-
Houston, TexasExcel Diagnostics and Nuclear Oncology Center
Jul 9, 2021
Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma Trial in Worldwide (Lutetium [177Lu]
Recruiting
- Gastroenteropancreatic Neuroendocrine Tumors
- +2 more
- Lutetium [177Lu] oxodotreotide/dotatate
-
Iowa City, Iowa
- +16 more
Apr 6, 2022
Metanephrines in Obstructive Sleep Apnoea
Recruiting
- Pheochromocytoma
- +2 more
- Measurement of Urine and plasma metanephrines
-
Singapore, SingaporeChangi General Hospital
Sep 14, 2021
Familial Investigations of Childhood Cancer Predisposition
Recruiting
- Acute Leukemia
- +45 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 11, 2022
Locally Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, Metastatic Paraganglioma Trial in Houston
Recruiting
- Locally Advanced Paraganglioma
- +5 more
- Cabozantinib S-malate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 7, 2021